Status:
COMPLETED
Stenting Malignant Jaundice for Quality of Life
Lead Sponsor:
Indiana University
Collaborating Sponsors:
American Society for Gastrointestinal Endoscopy
American College of Gastroenterology
Conditions:
Bile Duct Neoplasms Malignant
Eligibility:
All Genders
Phase:
NA
Brief Summary
Endoscopic stent insertion is considered the method of choice for palliation of malignant bile duct obstruction (MBDO). However, it can cause complications and requires periodic stent exchanges. While...
Detailed Description
Most malignant tumors causing bile duct obstruction, such as pancreatic adenocarcinoma, gallbladder carcinoma or cholangiocarcinoma, have an extremely poor prognosis. At the time of diagnosis the majo...
Eligibility Criteria
Inclusion
- Patients with suspected or proven malignant biliary obstruction who were unresectable or inoperable and were undergoing ERCP and biliary stenting for biliary depression.
Exclusion
- Had previously undergone biliary stenting
- Surgery was planned
- A guidewire could not be passed through the stricture
- Suspected survival of \< 3 months
- Impending duodenal obstruction
Key Trial Info
Start Date :
July 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2004
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT01459965
Start Date
July 1 1993
End Date
November 1 2004
Last Update
October 26 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.